Next Gen: What’s beyond the leading edge of biotech and pharma?
June 22–23, 2021 Virtual Event
BROUGHT TO YOU BY
We’re looking for the next generation.
New waves of cancer targets. Novel approaches to cell and gene therapies. Cutting-edge technologies set to change biopharma manufacturing. Even a new cohort of up-and-coming industry leaders. We’ll delve into all these subjects and more June 22-23 at Fierce’s next virtual event.
And take a walk with our new virtual event platform Brella, where you can schedule one-on-one meetings, participate in group chats with speakers, partners and attendees.
2021 Featured Speakers
Dave Lennon
Novartis Gene Therapies
President
Pearl Huang
Cygnal Therapeutics
CEO
Eric Rubin, M.D.
Merck Research Labs
SVP & Therapeutic Area Head, Oncology Early Development
Shankar Ramaswamy, M.D.
Kriya Therapeutics
CEO and Co-Founder
Bobby Gaspar, M.D., Ph.D.
Orchard Therapeutics
CEO and Co-Founder
Kristen Hege
Bristol Myers Squibb
SVP, Early Clinical Development, Oncology/Hematology and Cell Therapy
Alison Moore, Ph.D
Allogene
Chief Technical Officer
R. Nolan Townsend
LEXO Therapeutics
CEO
Camille Hertzka
AstraZeneca
Head of Medical Affairs, US Oncology
RA Session II
Taysha Gene Therapies
President, CEO and Founder
Sebastian Guth, Ph.D.
Bayer Pharmaceuticals
President, Americas Region
Mark Wildgust, Ph.D.
Janssen
Vice President, Global Medical Affairs, Oncology
The Fierce Virtual Event Difference
Expert Sessions
Learn from and engage with speakers and panelists by asking questions and chatting with your peers.
Networking
Connect with your peers through AI driven virtual matchmaking.
Content Hub
View and download content directly from our partners
Meetings
Virtual rooms where you can network one-on-one with attendees
Always On
Couldn’t make it live? No problem, watch the content on-demand for up to six months!
Sponsoring Organizations
PLATINUM SPONSOR
GOLD SPONSORS
